Previous studies have shown that the serum BDNF level of schizophrenia patients is lower than that of healthy individuals, while the levels of S100B and GFAP are higher than those of healthy individuals, and can be used as markers of nerve damage (34–36). Here, GFAP is linked to schizophrenia.